日韩欧美第一页快播,自拍操美女,国产欧美精品

2024 Global Top 10 Pharmaceutical Companies Market Trend The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
Top 10 Pharmaceutical Giants' R&D Investments in 2024 Market Trend In 2024, pharmaceutical giants face a quiet battle over innovation and efficiency. From Merck’s 41% R&D drop to AbbVie’s bold growth, their strategies and investments reveal shifting power in the industry. A glimpse into the future of drug development.
Top 16 Best-Selling New Drugs Worldwide in 2024 Market Trend Discover the top 16 best-selling new drugs of 2024, featuring innovative FIC and BIC molecules, breakthrough therapies across various fields, and products that stood out due to unique development strategies.
Top 10 Global Pharmaceutical Giants in Oncology Business for 2024 Oncology Discover the top 10 pharmaceutical giants leading the oncology industry in 2024. From Merck's dominance with Keytruda to AstraZeneca's rise, these companies are making strides in cancer treatment, innovation, and growth.
Pharmaceutical Giants Ranking 2024 Market Trend Explore the top pharmaceutical giants of 2024, including Merck, Johnson & Johnson, and more. Learn about their revenue, profits, R&D investments, and market value in this detailed ranking report.
AstraZeneca 2024 Financial Report Financial statements AstraZeneca’s 2024 financial results show strong growth with total revenue of $54.07 billion, driven by key products like Tagrisso, Farxiga, and Enhertu. China’s market contributed $6.4 billion, and the company expects continued high growth in 2025.
Top 10 Diabetes Medications to Watch in 2024 Diabetes Discover the top 10 diabetes medications of 2024, including Ozempic, Jardiance, and Mounjaro. Learn about their sales, innovations, and why they're leading in the treatment of diabetes and related conditions.
AstraZeneca Announces Major Developments AstraZeneca AstraZeneca announces a $3.5 billion investment in the U.S., upgrades its 2024 performance forecast, and submits a BLA for Trop2 ADC to treat EGFR-mutant NSCLC. Key developments aimed at growth and innovation.
MNC Profiles: Who Values ??the Chinese Market Most? AstraZeneca Explore the competitive landscape of multinational pharmaceutical companies (MNCs) in China’s booming healthcare market. Delves into MNC revenue trends, strategies, and insights, highlighting which companies value the Chinese market most.
Over $2 Billion! AstraZeneca Partners with CSPC Pharmaceutical Group AstraZeneca CSPC Pharmaceutical Group (1093.HK) has signed an exclusive licensing agreement with AstraZeneca to globally develop and commercialize CSPC's Lp(a) inhibitor, YS2302018. The deal includes a $100M upfront payment, with potential milestones up to $1.92B plus royalties.

< Pre 123 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水